As of April 29, 2025, AEON Biopharma (AEON) has a market cap of $4.318 million USD. According to our data, AEON Biopharma is ranked No.9051 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $4.32 M |
-90.00%
|
Dec 31, 2024 | $43.18 M |
-92.50%
|
Dec 29, 2023 | $0.58 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Revance Therapeutics
RVNC
|
$0.38 B |
0.000 M
|
![]() USA
|
![]() Evolus
EOLS
|
$0.74 B |
0.000 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$342.32 B |
-0.001 M
|
![]() USA
|
![]() Pfizer
PFE
|
$130.73 B |
-0.001 M
|
![]() USA
|
![]() Teva Pharmaceutical Industries
TEVA
|
$18.23 B |
0.362 B
|
![]() Israel
|
![]() Sanofi
SNY
|
$128.86 B |
0.003 M
|
![]() France
|
Market Cap | = | AEON Stock Price | * | AEON Shares Outstanding |
= | $0.41 | * | 10.53 M | |
= | $4.32 M |